GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Cyclically Adjusted PS Ratio

Bausch Health (FRA:BVF) Cyclically Adjusted PS Ratio : 0.25 (As of May. 13, 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Cyclically Adjusted PS Ratio?

As of today (2024-05-13), Bausch Health's current share price is €6.396. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €25.57. Bausch Health's Cyclically Adjusted PS Ratio for today is 0.25.

The historical rank and industry rank for Bausch Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:BVF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.17   Med: 1.26   Max: 27.37
Current: 0.25

During the past years, Bausch Health's highest Cyclically Adjusted PS Ratio was 27.37. The lowest was 0.17. And the median was 1.26.

FRA:BVF's Cyclically Adjusted PS Ratio is ranked better than
92.48% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs FRA:BVF: 0.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's adjusted revenue per share data for the three months ended in Mar. 2024 was €5.400. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €25.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted PS Ratio Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 0.94 1.10 0.24 0.28

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.29 0.30 0.28 0.38

Competitive Comparison of Bausch Health's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.



Bausch Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bausch Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.396/25.57
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.4/125.4675*125.4675
=5.400

Current CPI (Mar. 2024) = 125.4675.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.402 99.473 5.552
201409 4.675 99.394 5.901
201412 5.273 98.367 6.726
201503 5.839 99.789 7.342
201506 7.069 100.500 8.825
201509 7.074 100.421 8.838
201512 7.266 99.947 9.121
201603 6.176 101.054 7.668
201606 6.243 102.002 7.679
201609 6.320 101.765 7.792
201612 6.514 101.449 8.056
201703 5.626 102.634 6.878
201706 5.677 103.029 6.913
201709 5.285 103.345 6.416
201712 5.178 103.345 6.286
201803 4.613 105.004 5.512
201806 5.185 105.557 6.163
201809 5.208 105.636 6.186
201812 5.298 105.399 6.307
201903 5.079 106.979 5.957
201906 5.409 107.690 6.302
201909 5.692 107.611 6.636
201912 5.675 107.769 6.607
202003 5.152 107.927 5.989
202006 4.159 108.401 4.814
202009 5.073 108.164 5.885
202012 5.111 108.559 5.907
202103 4.772 110.298 5.428
202106 4.863 111.720 5.461
202109 4.930 112.905 5.479
202112 5.397 113.774 5.952
202203 4.827 117.646 5.148
202206 5.137 120.806 5.335
202209 5.686 120.648 5.913
202212 5.709 120.964 5.922
202303 4.998 122.702 5.111
202306 5.448 124.203 5.503
202309 5.739 125.230 5.750
202312 6.032 125.468 6.032
202403 5.400 125.468 5.400

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (FRA:BVF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bausch Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (FRA:BVF) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines